Vir Biotechnology
VIR
VIR
225 hedge funds and large institutions have $2.23B invested in Vir Biotechnology in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 87 increasing their positions, 72 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
6% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 34
2% less funds holding
Funds holding: 230 → 225 (-5)
55% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $32M
Holders
225
Holding in Top 10
3
Calls
$14.4M
Puts
$32M
Top Buyers
| 1 | +$44.5M | |
| 2 | +$24.9M | |
| 3 | +$24M | |
| 4 |
Walleye Capital
New York
|
+$21.2M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$15.9M |
Top Sellers
| 1 | -$40.1M | |
| 2 | -$28.7M | |
| 3 | -$16.7M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$7.18M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6.59M |